| Drug Type CpG ODN | 
| Synonyms NanoZolid-TLR9 agonist, TLR9 agonist - LIDDS, NZ TLR9 + [1] | 
| Target | 
| Action agonists | 
| Mechanism TLR9 agonists(Toll like receptor 9 agonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Solid tumor | Preclinical | Sweden  | - | 





